Am J Hypertens
- HIRA S
Methodological and Statistical Considerations for Circulating miR-23b-3p in
Hypertensive Nephropathy.
Am J Hypertens. 2026 Oct 1:hpag120. doi: 10.1093.
- LIU EY, Lee G, Khan MM, Petriceks A, et al
Effects of Anti-Hypertensive Agents on Orthostatic Changes: Secondary Analysis of
the Treatment of Mild Hypertension Study (TOMHS).
Am J Hypertens. 2026 Oct 1:hpag119. doi: 10.1093.
Am J Med
- GOLDHABER SZ, Rashedi S, Pfeferman M, Amalan C, et al
Alert-Based Computerized Decision Support to Increase Screening for Pulmonary
Hypertension after Pulmonary Embolism: The CTEPH-DETECT Trial.
Am J Med. 2026 Sep 30:S0002-9343(26)00700-X. doi: 10.1016/j.amjmed.2026.
- RAM CVS, Chopra VK
A New Class of Drugs Approved in the United States for Hypertension: Aldosterone
Synthase Inhibitors.
Am J Med. 2026 Sep 26:S0002-9343(26)00681-9. doi: 10.1016/j.amjmed.2026.
Am J Med Sci
- KABALAK PA, Soyler Y, Cengiz TI, Celik M, et al
Management of Pulmonary Hypertension in Interstitial Lung Disease Without Access
to Inhaled Treprostinil: A Case Series from a Resource-Limited Setting.
Am J Med Sci. 2026 Oct 2:S0002-9629(26)00366-6. doi: 10.1016/j.amjms.2026.
Circ Genom Precis Med
- CHEONG P, Mangan C, Clarke ED, Stanford J, et al
Personalized Nutrition for Hypertension: Current Evidence and Future Directions.
Circ Genom Precis Med. 2026 Oct 2:e005566. doi: 10.1161/CIRCGEN.125.005566.
Clin Exp Hypertens
- CHEN Z, Chunbin W, Zhang H, Luo T, et al
Efficacy and mechanistic insights of dapagliflozin in hypertension management.
Clin Exp Hypertens. 2026;48:2731624.
- TANG W, Cai J, Zhang S, Li Y, et al
Preliminary study of individualized therapy for ventricular septal defect with
severe pulmonary arterial hypertension.
Clin Exp Hypertens. 2026;48:2734004.
- MCMILLAN R, Saleem M, Thorson A, Pierre-Louis O, et al
Chemerin - CMKLR1 signaling contributes to immune metabolic dysfunction in
salt-sensitive hypertension.
Clin Exp Hypertens. 2026;48:2736024.
Hypertension
- GUPTA A, Collier D, Steckelmacher J, Field J, et al
Safety, Acceptability and Efficacy of Noninvasive Transcutaneous-Autonomic
Neuromodulation in Uncontrolled Hypertension.
Hypertension. 2026 Sep 28. doi: 10.1161/HYPERTENSIONAHA.126.27847.
- TANG D, Goubar A, Pantoja-Ruiz C, Bhalla A, et al
Frailty Index Progression Around Hypertension Diagnosis in 14 Countries.
Hypertension. 2026 Sep 30. doi: 10.1161/HYPERTENSIONAHA.126.27590.
J Am Coll Cardiol
- CHIU L, Pandey A
Cardiovascular Health Trajectories After a Community-Based Hypertension
Intervention: When the Benefit Follows the Target.
J Am Coll Cardiol. 2026 Sep 17:S0735-1097(26)07604.
J Hum Hypertens
- ESPECHE W, Minetto J, Cerri G, Todoroff J, et al
Apparent versus true resistant hypertension in a real-world argentine cohort.
J Hum Hypertens. 2026 Sep 30. doi: 10.1038/s41371-026-01234.
- MINETTO J, Espeche W, Cerri G, Giordani E, et al
Association between the triglyceride/high-density lipoprotein cholesterol ratio
and isolated nocturnal hypertension.
J Hum Hypertens. 2026 Sep 25. doi: 10.1038/s41371-026-01230.
- KHAN W, Kalhoro S
The vaping paradox in hypertension; A South Asian perspective.
J Hum Hypertens. 2026 Sep 25. doi: 10.1038/s41371-026-01235.
Nephrol Dial Transplant
- KANBAY M, Copur S, Sarafidis P, Ferro CJ, et al
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the
prevention, detection, evaluation and management of high blood pressure in
adults: a commentary from the European Renal Best Practice (ERBP).
Nephrol Dial Transplant. 2026;41:1909-1918.
PLoS One
- AGRAWAL R, Delen D, Benjamin B, Misra R, et al
Age- and sex-stratified prevalence of obstructive sleep apnea and stroke risk
comorbidities: A large cross-sectional EHR study.
PLoS One. 2026;21:e0357824.
- HORMENU T, Antiri EO, Awlime-Ableh E, Paku JE, et al
Prevalence and risk factors of cardiometabolic disease among informal sector
workers in Cape Coast, Ghana: Insights from the CarMeR study.
PLoS One. 2026;21:e0359530.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016